Stock 002817 ANHUI HUANGSHAN CAPSULE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Anhui Huangshan Capsule Co., Ltd.

Equities

002817

CNE100002BV5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
6.37 CNY +0.79% Intraday chart for Anhui Huangshan Capsule Co., Ltd. +3.92% -27.28%
Mar. 25 Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
2023 Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 2,662 1,491 1,961 1,955 2,577 2,680
Enterprise Value (EV) 1 2,324 1,149 1,602 1,629 2,292 2,310
P/E ratio 56.9 x 42 x 50.3 x 43.2 x 45.3 x 44.8 x
Yield 0.36% 0.49% 0.42% 0.45% 0.66% 0.67%
Capitalization / Revenue 9.31 x 5.06 x 6.02 x 6.12 x 6.78 x 6.26 x
EV / Revenue 8.13 x 3.9 x 4.92 x 5.1 x 6.03 x 5.39 x
EV / EBITDA 37.4 x 22.6 x 28.2 x 26.2 x 29 x 26.8 x
EV / FCF 596 x -493 x 217 x -59.5 x -47.3 x 106 x
FCF Yield 0.17% -0.2% 0.46% -1.68% -2.11% 0.94%
Price to Book 4 x 2.15 x 2.71 x 2.57 x 3.18 x 3.14 x
Nbr of stocks (in thousands) 299,098 299,098 299,098 299,098 299,098 299,098
Reference price 2 8.899 4.984 6.558 6.537 8.614 8.960
Announcement Date 4/20/18 4/25/19 4/24/20 4/27/21 3/10/22 4/27/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 286 294.7 325.6 319.4 379.9 428.3
EBITDA 1 62.09 50.79 56.8 62.24 79.05 86.2
EBIT 1 38.4 25.86 28.11 33 45.76 43.77
Operating Margin 13.43% 8.78% 8.63% 10.33% 12.04% 10.22%
Earnings before Tax (EBT) 1 53.88 39.46 42.79 49.57 61.86 60.87
Net income 1 46.42 35.97 39.13 45.26 56.89 60.85
Net margin 16.23% 12.2% 12.02% 14.17% 14.97% 14.21%
EPS 2 0.1565 0.1188 0.1304 0.1513 0.1902 0.2000
Free Cash Flow 1 3.9 -2.33 7.385 -27.4 -48.48 21.73
FCF margin 1.36% -0.79% 2.27% -8.58% -12.76% 5.07%
FCF Conversion (EBITDA) 6.28% - 13% - - 25.21%
FCF Conversion (Net income) 8.4% - 18.87% - - 35.72%
Dividend per Share 2 0.0319 0.0246 0.0275 0.0296 0.0571 0.0600
Announcement Date 4/20/18 4/25/19 4/24/20 4/27/21 3/10/22 4/27/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 338 342 359 326 284 370
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 3.9 -2.33 7.38 -27.4 -48.5 21.7
ROE (net income / shareholders' equity) 7.16% 5% 5.12% 5.85% 7.06% 7.33%
ROA (Net income/ Total Assets) 3.34% 2.13% 2.18% 2.36% 2.9% 2.62%
Assets 1 1,391 1,690 1,795 1,918 1,959 2,326
Book Value Per Share 2 2.230 2.320 2.420 2.550 2.710 2.850
Cash Flow per Share 2 0.8300 1.140 0.6900 0.8100 1.150 1.070
Capex 1 27.5 33.2 24.7 93.8 75.8 34.1
Capex / Sales 9.61% 11.28% 7.59% 29.36% 19.96% 7.97%
Announcement Date 4/20/18 4/25/19 4/24/20 4/27/21 3/10/22 4/27/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ANHUI HUANGSHAN CAPSULE CO., LTD. Stock Anhui Huangshan Capsule Co., Ltd.
-27.28% 263M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002817 Stock
  4. Financials Anhui Huangshan Capsule Co., Ltd.